Medical Facilities Corporation (TSX:DR)
Canada
· Delayed Price · Currency is CAD 15.97
+0.05 (0.31%)
Mar 28, 2025, 4:00 PM EST
Medical Facilities Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 331.53 | 339.58 | 424.55 | 398.63 | 363.85 | Upgrade
|
Revenue Growth (YoY) | -2.37% | -20.02% | 6.50% | 9.56% | -8.60% | Upgrade
|
Cost of Revenue | 202.11 | 209.31 | 271.28 | 249.93 | 235.45 | Upgrade
|
Gross Profit | 129.42 | 130.26 | 153.27 | 148.71 | 128.4 | Upgrade
|
Selling, General & Admin | 60.65 | 62.78 | 70.86 | 57.68 | 58.73 | Upgrade
|
Operating Expenses | 77.47 | 81.09 | 91.62 | 84.45 | 86.62 | Upgrade
|
Operating Income | 51.95 | 49.18 | 61.65 | 64.26 | 41.79 | Upgrade
|
Interest Expense | -12.09 | -13.25 | -12.89 | -14.2 | -14.35 | Upgrade
|
Interest & Investment Income | 1.08 | 0.72 | 0.32 | 0.08 | 2.3 | Upgrade
|
Earnings From Equity Investments | - | -0.32 | -0.57 | -0.13 | -1.84 | Upgrade
|
Currency Exchange Gain (Loss) | -0.06 | -0.03 | -0 | -0.03 | -0.05 | Upgrade
|
Other Non Operating Income (Expenses) | 0.54 | -3.08 | 7.7 | -12.19 | -12.76 | Upgrade
|
EBT Excluding Unusual Items | 41.42 | 33.21 | 56.2 | 37.79 | 15.09 | Upgrade
|
Impairment of Goodwill | -2.27 | - | -15.36 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | 2.49 | - | - | - | Upgrade
|
Asset Writedown | - | - | -1.19 | - | - | Upgrade
|
Other Unusual Items | 11.96 | -0.79 | -22.15 | 13.1 | 26.69 | Upgrade
|
Pretax Income | 51.11 | 34.91 | 17.5 | 50.89 | 41.78 | Upgrade
|
Income Tax Expense | -5.69 | 6.06 | 5.21 | 4.4 | 4.36 | Upgrade
|
Earnings From Continuing Operations | 56.79 | 28.85 | 12.3 | 46.49 | 37.42 | Upgrade
|
Earnings From Discontinued Operations | 48.77 | 15.15 | - | - | -1.74 | Upgrade
|
Net Income to Company | 105.56 | 44 | 12.3 | 46.49 | 35.68 | Upgrade
|
Minority Interest in Earnings | -32.07 | -25.5 | -16.7 | -30.99 | -26.87 | Upgrade
|
Net Income | 73.49 | 18.5 | -4.41 | 15.5 | 8.81 | Upgrade
|
Net Income to Common | 73.49 | 18.5 | -4.41 | 15.5 | 8.81 | Upgrade
|
Net Income Growth | 297.18% | - | - | 75.88% | -10.29% | Upgrade
|
Shares Outstanding (Basic) | 24 | 25 | 29 | 31 | 31 | Upgrade
|
Shares Outstanding (Diluted) | 24 | 25 | 29 | 31 | 31 | Upgrade
|
Shares Change (YoY) | -4.96% | -14.00% | -5.65% | 0.07% | -16.04% | Upgrade
|
EPS (Basic) | 3.06 | 0.73 | -0.15 | 0.50 | 0.28 | Upgrade
|
EPS (Diluted) | 3.06 | 0.73 | -0.15 | 0.50 | 0.28 | Upgrade
|
EPS Growth | 319.18% | - | - | 78.04% | - | Upgrade
|
Free Cash Flow | 76.22 | 56.66 | 50.3 | 67.22 | 105.76 | Upgrade
|
Free Cash Flow Per Share | 3.18 | 2.24 | 1.71 | 2.16 | 3.40 | Upgrade
|
Dividend Per Share | 0.242 | 0.242 | 0.238 | 0.230 | 0.220 | Upgrade
|
Dividend Growth | -0.33% | 1.85% | 3.64% | 4.46% | -71.04% | Upgrade
|
Gross Margin | 39.04% | 38.36% | 36.10% | 37.30% | 35.29% | Upgrade
|
Operating Margin | 15.67% | 14.48% | 14.52% | 16.12% | 11.48% | Upgrade
|
Profit Margin | 22.17% | 5.45% | -1.04% | 3.89% | 2.42% | Upgrade
|
Free Cash Flow Margin | 22.99% | 16.69% | 11.85% | 16.86% | 29.07% | Upgrade
|
EBITDA | 61.07 | 60.01 | 71.58 | 80.86 | 59.55 | Upgrade
|
EBITDA Margin | 18.42% | 17.67% | 16.86% | 20.28% | 16.37% | Upgrade
|
D&A For EBITDA | 9.12 | 10.84 | 9.93 | 16.6 | 17.77 | Upgrade
|
EBIT | 51.95 | 49.18 | 61.65 | 64.26 | 41.79 | Upgrade
|
EBIT Margin | 15.67% | 14.48% | 14.52% | 16.12% | 11.48% | Upgrade
|
Effective Tax Rate | - | 17.37% | 29.75% | 8.64% | 10.43% | Upgrade
|
Revenue as Reported | 343.49 | 339.58 | 414.39 | 411.73 | 389.86 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.